
    		<div class="entry-content">
    <section id="about" class="container content-section text-center">
        <div class="row">
            <div class="col-lg-8 col-lg-offset-2">
              <br/>
              </div>
        </div>

		<header class="entry-header">
			<h1 class="entry-title">Overview (physicians &#038; pharmacists)</h1>
		</header>

		<div class="entry-content">
			<div class="arrow_box_white" id="first" style="z-index: 12;">
<h1>The problem</h1>
</p>
<div class="box-wrapper">
<div class="text-box-3-columns">
<div class="learnmore" align="center">
				<a href="#"><span class="fea-icon1"><br />
<h1>10,1%</h1>
<p></span></a></p>
<p>of hospitalized patients experience adverse drug reactions<sup>1</sup></p>
</div>
</div>
<div class="text-box-3-columns">
<div class="learnmore" align="center">
				<a href="#"><span class="fea-icon1"><br />
<h1>3,5%</h1>
<p></span></a></p>
<p>of hospital admissions are related to adverse drug reactions<sup>1</sup></p>
</div>
</div>
<div class="text-box-3-columns">
<div class="learnmore" align="center">
				<a href="#"><span class="fea-icon1"><br />
<h1>4th</h1>
<p></span></a></p>
<p>Adverse drug reactions are the 4th leading cause of death in the USA<sup>2</sup></p>
</div>
</div>
</div>
</div>
<div class="arrow_box_grey" style="z-index: 12;">
<div class="box-wrapper">
<div class="text-box-2-columns">
<h4>The response to a specific medication can differ widely between different patients</h4>
<p>Currently, medications are prescribed in a <strong>“one-size-fits-all”</strong> approach. However, every patient is different and so is their response to certain drugs. While a certain medication might show good efficacy in one person without causing any adverse drug events, another person might experience <strong>severe adverse drug reactions</strong> when taking the same drug. These differences can partly be attributed to each patient’s individual genetic make-up.
</div>
<div class="text-box-2-columns">
<img src="{{ site.baseurl }}/landing-page-theme/img/different_people_same_prescription.png" class="aligncenter">
</div>
</div>
</div>
<div class="arrow_box_white" style="z-index: 10;">
<h1>A possible solution</h1>
<h2> The Medication Safety Code System</h2>
<div class="arrow_box_grey" style="z-index: 12;">
<h4>The Medication Safety Code system captures pharmacogenomic test results and enables the quick retrieval of relevant pharmacogenomic drug dosing guidelines</h4>
<div class="box-wrapper">
<div class="text-box-3-columns">
<p>
A small set of so-called pharmacogenes has an impact on the safety and efficacy of many common medications. <strong>Pharmacogenomic (PGx) tests</strong> can detect variations in these pharmacogenes based on a blood or saliva sample of the patient. The <strong>Medication Safety Code (MSC)</strong> captures these PGx test results to make them available whenever needed during medical care.</p>
</div>
<div class="text-box-3-columns">
<p>Medication Safety Codes can be printed on <strong>personalized cards</strong> that patients can carry in their wallet, or they can be incorporated in paper-based lab reports. After scanning the QR code with a standard smartphone, you are led to a website that displays <strong> drug dosing recommendations extracted from pharmacogenomic guidelines</strong> that are highly relevant for the patient based on his or her PGx test results.</p>
</div>
<div class="text-box-3-columns">
<img src="{{ site.baseurl }}/landing-page-theme/img/basic.png" class="aligncenter"></div>
</div>
</div>
<div class="arrow_box_white" style="z-index: 12;">
<h1>Benefits</h1>
<div class="arrow_box_grey" style="z-index: 12;">
<div class="box-wrapper">
<div class="text-box-3-columns">
<ul>
<li>Knowing a patient’s pharmacogenetic variants can help you <strong>individualize</strong> his or her drug therapy and thus <strong>reduce the risk for adverse drug reactions and ineffective treatments</strong>.</li>
</ul>
</div>
<div class="text-box-3-columns">
<ul>
<li><strong>Over half</strong> of all Caucasian patients exhibit <strong>at least one</strong> pharmacogenetic variant in one of the 8 most relevant pharmacogenes with <strong>significant therapeutic implications</strong>.</li>
</ul>
</div>
<div class="text-box-3-columns">
<ul>
<li><strong>Over 30%</strong> of all patients older than 40 receive <strong>at least one drug</strong> for which pharmacogenetic dosing guidelines are available.</li>
</ul>
</div></div>
</div>
</div>
<div class="arrow_box_white" style="z-index: 12;">
<h1>Privacy and data security</h1>
<div class="arrow_box_grey" style="z-index: 12;">
<div class="box-wrapper">
<div class="text-box-3-columns">
<ul>
<li>The MSC system <strong>does not require central data storage</strong>: all pharmacogenetic data are inside the QR code and remain anonymous.</li>
</ul>
</div>
<div class="text-box-3-columns">
<ul>
<li><strong>Patients can opt-in and opt-out at any time</strong>: Patients can choose whether or not to carry their anonymized pharmacogenomic data in their pockets and make their data available to care providers.</li>
</ul>
</div>
<div class="text-box-3-columns">
<ul>
<li>
<strong>The MSC captures only PGx data that can be used to optimize a patient&#8217;s drug therapy.</strong> No other sensitive health data (e.g. current medication or diseases) are captured.
</li>
</ul>
</div>
</div>
</div>
</div>
<h1>Demo</h1>
<div class="arrow_box_grey" style="z-index: 6;">
<p>Below you can see exemplary illustrations of the MSC pocket card and corresponding website that displays the patient-tailored drug dosing recommendations for a fictional patient named &#8220;Jane Doe&#8221;. <strong>If you want to try it out for yourself, you can either scan the QR code displayed below with your smart phone, or you access the site directly by clicking on this link: <a href="http://safety-code.org/msc3/00/000101100101200101300101400101500101600101750101800101970108A00101B00101C00101D00101G00101H00101J00102K50405L00101M00102" target="_blank">Demo site</a>.</strong></p>
<div class="box-wrapper">
<h2>Pocket card</h2>
<div class="text-box-2-columns">
<p><img src="{{ site.baseurl }}/landing-page-theme/img/back.png" class="alignright">
</div>
<div class="text-box-2-columns">
<h3>Front side</h3>
<ul>
<li>The front side of the pocket card contains the <strong>MSC QR code</strong>, <strong>contact details</strong> of the <strong>laboratory</strong> in charge and a short description of the MSC&#8217;s purpose and functionality.</li>
</ul>
<ul>
<li>The MSC can be decoded with any common<strong> QR code reader app </strong>on your smartphone or tablet. In many cases, such apps come pre-installed. For example, many Android devices come pre-installed with an application called <a href="https://play.google.com/store/apps/details?id=com.google.android.apps.unveil" target="_blank">Google Goggles</a>. Simply activate the app and point the camera of your mobile phone towards the MSC QR code. </li>
</ul>
</div>
</div>
<p></p>
<div class="box-wrapper">
<div class="text-box-2-columns">
<p><img src="{{ site.baseurl }}/landing-page-theme/img/back1.png" class="alignright">
</div>
<div class="text-box-2-columns">
<h3>Back side</h3>
<ul>
<li>The back side of the pocket card contains the patient&#8217;s <strong>indentifying information</strong>, the <strong>card number</strong> and <strong>printing date</strong> of the card, and a tabulated overview of the patient&#8217;s <strong>pharmacogenomic profile</strong>.</li>
</ul>
<ul>
<li>The table lists the patient&#8217;s <strong>atypical phenotypes</strong> (e.g. &#8220;CYP2C19 poor metabolizer&#8221;) and all <strong>drug substances</strong> for which essential therapy modifications are recommended based on the patient&#8217;s phenotype. These patient-specific recommendations are displayed on your smartphone after scanning the MSC code. </li>
</ul>
<ul>
<li>The bottom row lists all genes that were included in the PGx test but did not result in any significant therapeutic recommendations.</li>
</ul>
</div>
</div>
<p></p>
<div class="box-wrapper">
<h2>User interface</h2>
<div class="text-box-2-columns">
<img style="max-width: 350px;" src="{{ site.baseurl }}/landing-page-theme/img/ui.png" width=100% alt="" border="0" class="aligncenter" />
</div>
<div class="text-box-2-columns">
<ul>
<li>After scanning the MSC code you are led to a website that lists <strong>all drug substances for which important recommendations are available</strong> for the card owner. By clicking on the substance name the corresponding recommendation text folds out.</li>
</ul>
<ul>
<li>Each recommendation is also accompanied by the following information: <strong>reason</strong> for the recommendation (e.g. TPMT poor metabolizer), the <strong>publishing date</strong> of the recommendation, and a link to the <strong>Pharmacogenomics Knowledgebase (PharmGKB)</strong> website (&#8216;Show guideline website&#8217;) for further reference. </li>
</ul>
<ul>
<li>The recommendations displayed by the MSC system are based on clinical guidelines authored by an <strong>expert consortium</strong>: the<strong> Dutch Pharmacogenetics Working Group (DPWG)</strong>. </li>
</ul>
<ul>
<li>You can use the <strong>search field</strong> at the top to search for drug substances and <strong>trade names</strong>.</li>
</ul>
<ul>
<li>To view the patient&#8217;s <strong>raw PGx test results</strong> simply scroll down to the bottom of the page and click on &#8216;Show pharmacogenomic data&#8217;.</li>
</ul>
</div>
</div>
</div>
<div class="arrow_box_white" style="z-index: 5;">
<h1>Interested?</h1>
<div class="arrow_box_grey" style="z-index: 4;">
	<p>If you are interested in using the MSC system, please <a href="/contact">contact us</a>. You can also download additional infomaterial in the <a href="#download">download section</a> or have a look at our <a href="#FAQ">FAQ section</a>.</p>
</div>
</div>
<div class="arrow_box_white" style="z-index: 4;">
<h1 id="FAQ">Frequently asked questions</h1>
<h2>Pharmacogenomics</h2>

<details><summary><div id="faq-111" class="arconix-faq-wrap"><div id="faq-WhatisPharmacogenomics" class="arconix-faq-title faq-closed">What is Pharmacogenomics?</div></div></summary>
<div class="arconix-faq-content faq-closed"><strong>Pharmacogenomics (PGx)</strong> is the study of <strong>how genetic variations influence a person’s response to drugs</strong>. The aim of PGx is to enable <strong>patient-tailored</strong> and thus <strong>safer</strong> and <strong>more effective</strong> medical therapies in contrast to the currently applied “one size fits all” approach.
</div></details>

	<details><summary><div id="faq-114" class="arconix-faq-wrap"><div id="faq-Whatarepharmacogenes" class="arconix-faq-title faq-closed">What are pharmacogenes?</div></div></summary><div class="arconix-faq-content faq-closed"><p>The term ‘pharmacogene’ refers to <strong>all genes that play a role in drug response</strong>.</p>
</div></details><details>
	<summary><div id="faq-116" class="arconix-faq-wrap"><div id="faq-WhatarePGxmarkers" class="arconix-faq-title faq-closed">What are PGx markers?</div></div></summary><div class="arconix-faq-content faq-closed"><p>PGx markers are indicators of an individual’s anticipated response to a certain drug. Commonly, PGx markers are <strong>single nucleotide polymorphisms</strong> (<strong>SNPs</strong>, pronounced “snips”) that affect individual pharmacogenes. SNPs are DNA variations  at the nucleotide level. For example, while in most people the nucleotide cytosine (C) occurs at a certain position in the genome, in some people cytosine might be replaced with the nucleotide adenosine (A). Another example are <strong>copy-number variations (CNVs)</strong>. CNVs are alterations in the number of copies of a particular gene.</p>
</div></details><details>
			<summary><div id="faq-118" class="arconix-faq-wrap"><div id="faq-HowdoSNPsandCNVsimpactdrugresponse" class="arconix-faq-title faq-closed">How do SNPs and CNVs impact drug response?</div></div></summary><div class="arconix-faq-content faq-closed"><p>A frequent mechanism is that SNPs and CNVs <strong>alter the activity of drug-metabolizing enzymes</strong>, such as the Cytochrome P450 (CYP) enzymes. This can lead to increased or decreased degradation or activation of drug substances respectively pro-drugs.</p></div></details>
<details>
		<summary><div id="faq-120" class="arconix-faq-wrap"><div id="faq-Whatarephenotypes" class="arconix-faq-title faq-closed">What are phenotypes?</div></div></summary><div class="arconix-faq-content faq-closed"><p>Genomic alterations, such as <strong>SNPs</strong> or <strong>copy-number variations (CNVs)</strong>, that change the efficacy of pharmacogenes can dictate the stratification of patients into metabolizer phenotypes for specific drugs, such as:</p>
<ul>
<li>Ultrarapid metabolizer (UM)</li>
<li>Extensive metabolizer (EM)</li>
<li>Intermediate metabolizer (IM)</li>
<li>Poor metabolizer (PM)</li>
</ul>
<p>This classification can help choosing the right dosage and avoiding potentially hazardous medication choices by providing insights into the expected response of the individual patient.</p>
</div></details>
<details><summary><div id="faq-122" class="arconix-faq-wrap"><div id="faq-WhataresomeexamplesofdrugsandassociatedadversedrugreactionsthatcanpotentiallybepreventedwithPGx-guideddrugdosing" class="arconix-faq-title faq-closed">What are some examples of drugs and associated adverse drug reactions that can potentially be prevented with PGx-guided drug dosing?</div></div></summary><div class="arconix-faq-content faq-closed"><table>
<tbody>
<tr>
<th>Drug class</th>
<th>Drugs</th>
<th>Examples of adverse reactions</th>
</tr>
<tr>
<td>Antidepressants</td>
<td>Amitriptyline, Citalopram, Clomipramine, Imipramine</td>
<td>Cardiotoxicity, therapy failure</td>
</tr>
<tr>
<td>Antiplatelet drugs</td>
<td>Clopidogrel</td>
<td>Therapy failure</td>
</tr>
<tr>
<td>Antipsychotics</td>
<td>Aripiprazole, Risperidone</td>
<td>Extrapyramidal symptoms</td>
</tr>
<tr>
<td>Analgesics</td>
<td>Codeine</td>
<td>Decreased pain relief, respiratory depression</td>
</tr>
<tr>
<td>Thiopurines</td>
<td>Azathioprine, Thioguanine, Mercaptopurine</td>
<td>Myelosuppression</td>
</tr>
</tbody>
</table>
</div>
</details>

<details><summary>	<div id="faq-124" class="arconix-faq-wrap"><div id="faq-HowdoPGxtestswork" class="arconix-faq-title faq-closed">How do PGx tests work?</div></summary><div class="arconix-faq-content faq-closed"><p>There are two main methods of obtaining information about an individual’s pharmacogenomic profile: genotyping tests and sequencing tests. <strong>Sequencing tests</strong> are used to read the exact nucleotide sequence  of the whole genome or parts of it. In contrast, <strong>genotyping tests</strong> are used to determine the presence of certain previously defined variants. Usually, PGx tests are performed by using <strong>saliva or blood samples.</strong></p>
</div></details><details><summary>	<div id="faq-126" class="arconix-faq-wrap"><div id="faq-WhatisthedifferencebetweenPGxandpredictivegenetictests" class="arconix-faq-title faq-closed">What is the difference between PGx and predictive genetic tests?</div></summary><div class="arconix-faq-content faq-closed"><p>Predictive genetic tests are used to determine predispositions for certain diseases whereas <strong>PGx tests focus solely on drug response</strong>.</p>
</div></details><details><summary>	<div id="faq-550" class="arconix-faq-wrap"><div id="faq-WhatarethecostsofPGxtests" class="arconix-faq-title faq-closed">What are the costs of PGx tests?</div></summary><div class="arconix-faq-content faq-closed"><p>Currently, the costs for standard PGx tests that analyse the most important pharmacogenes are <strong>less than 300€.</strong></p>
</div></details><details><summary>	<div id="faq-558" class="arconix-faq-wrap"><div id="faq-ArePGxtestscurrentlycoveredbyhealthinsurances" class="arconix-faq-title faq-closed">Are PGx tests currently covered by health insurances?</div></summary><div class="arconix-faq-content faq-closed"><p>Unfortunately, the costs for PGx tests are currently not covered by European health insurances.</p>
</div></details><details><summary>	<div id="faq-555" class="arconix-faq-wrap"><div id="faq-Wherecanmypatientsgettested" class="arconix-faq-title faq-closed">Where can my patients get tested?</div></summary><div class="arconix-faq-content faq-closed"><p>If you are interested in using the MSC system to make your patients’ therapies safer and more effective please contact us via the <a href="http://owl.msi.meduniwien.ac.at/safety-code-org/wordpress/about-us/">contact form</a> on this website.</p>
	</div></details></p>
<h2>Medication Safety Code System</h2>
		<details><summary><div id="faq-593" class="arconix-faq-wrap"><div id="faq-WhatisaQRcode" class="arconix-faq-title faq-closed">What is a QR code?</div></summary><div class="arconix-faq-content faq-closed"><p>A QR (quick response) code is a two-dimensional barcode that consists of black square dots arranged in a square grid on a white background. QR codes can be scanned with QR code readers (e.g. with an app on your smartphone) that convert the code into a useful form, in case of the MSC into a web address.</p>
</div></details><details><summary><div id="faq-597" class="arconix-faq-wrap"><div id="faq-WhatdoestheMSCcontain" class="arconix-faq-title faq-closed">What does the MSC contain?</div></summary><div class="arconix-faq-content faq-closed"><p>The MSC contains <strong>PGx test results in a compressed form</strong>, i.e. encoded in digits and letters. This sequence of digits and letters double-act as a web address that leads to a service for decoding and interpreting these data. The MSC itself <strong>does not contain any identifying information</strong> (e.g. name or birth date).</p>
</div></details><details><summary><div id="faq-492" class="arconix-faq-wrap"><div id="faq-IstheMSCsystemforfree" class="arconix-faq-title faq-closed">Is the MSC system for free?</div></summary><div class="arconix-faq-content faq-closed"><p>Use of the MSC system itself to retrieve the patient-specific drug dosing recommendations is for free. The only costs to be considered are those that arise from the one-time PGx test.</p>
</div> </details><details><summary><div id="faq-143" class="arconix-faq-wrap"><div id="faq-WheredotherecommendationsdisplayedbytheMSCsystemcomefrom" class="arconix-faq-title faq-closed">Where do the recommendations displayed by the MSC system come from?</div></summary><div class="arconix-faq-content faq-closed"><p>The recommendations displayed by the MSC system are authored by the <strong>Dutch Pharmacogenetics Working Group (DPWG)</strong>, a consortium that develops PGx guidelines based on extensive literature review.</p>
</div></details><details><summary><div id="faq-145" class="arconix-faq-wrap"><div id="faq-Howmanyguidelinesarecurrentlyavailable" class="arconix-faq-title faq-closed">How many guidelines are currently available?</div></summary><div class="arconix-faq-content faq-closed"><p>Currently, the MSC system’s knowledge base encompasses guidelines for <strong>54 different drug substances</strong>. A complete list of all drug substances can be found <a href="http://owl.msi.meduniwien.ac.at/safety-code-org/wordpress/wp-content/uploads/2015/12/drugs_overview_DPWG.pdf" target="_blank">here</a>.</p>
</div></details><details><summary><div id="faq-147" class="arconix-faq-wrap"><div id="faq-CanIaccesstherecommendationswithoutaQRcodescanner" class="arconix-faq-title faq-closed">Can I access the recommendations without a QR code scanner?</div></summary><div class="arconix-faq-content faq-closed"><p>Accessing the mobile site that displays all relevant patient-specific recommendations is only possible by scanning the QR code. Nevertheless, there are <strong>two alternative ways</strong> to access the recommendations if you don’t have a QR code scanner available: Besides generating a pocket card, the PGx test results and corresponding patient-specific recommendations can also be incorporated into a <strong>lab report sheet</strong> (digital or paper). Furthermore, the <strong>back side of the pocket card</strong> lists all of the patient’s <strong>relevant phenotype</strong>s. You can use this information to look up the drug dosing recommendations at a trusted source, e.g. http://www.pharmgkb.com.</p>
</div></details><details><summary><div id="faq-516" class="arconix-faq-wrap"><div id="faq-WherecanIgetaQRcodereader" class="arconix-faq-title faq-closed">Where can I get a QR code reader?</div></summary><div class="arconix-faq-content faq-closed"><p>In many cases, QR code reader app come pre-installed on mobile devices. For example, many Android devices come pre-installed with an application called <a href="https://play.google.com/store/apps/details?id=com.google.android.apps.unveil" target="_blank">Google Goggles</a>. Another Android app would be <a href="https://play.google.com/store/apps/details?id=la.droid.qr" target="_blank">QR Droid</a>. iPhone/iPad users can try the <a href="https://itunes.apple.com/en/app/qr-reader-for-iphone/id368494609?mt=8" target="_blank">QR Reader</a> app.</p>
</div></details><details><summary><div id="faq-149" class="arconix-faq-wrap"><div id="faq-CanthePGxdataintheQRcodebecomeoutdated" class="arconix-faq-title faq-closed">Can the PGx data in the QR code become outdated?</div></summary><div class="arconix-faq-content faq-closed"><p>PGx test results have <strong>lifelong validity</strong>. Therefore, testing of the most relevant pharmacogenes that are responsible for the largest part of variance in drug metabolism and drug response has significant clinical implications throughout an individual’s lifespan. In the future, additional drug dosing guidelines may become available. However, this does not affect the validity of the PGx data in the QR code.</p>
</div></details><details><summary><div id="faq-904" class="arconix-faq-wrap"><div id="faq-DoestheMSCsystemperformanycalculationstodisplaythedrugdosingrecommendations" class="arconix-faq-title faq-closed">Does the MSC system perform any calculations to display the drug dosing recommendations?</div></summary><div class="arconix-faq-content faq-closed"><p>No, the MSC operates without using any complex algorithms or calculations. It uses a simple search to match the patient&#8217;s phenotypes (as printed on the MSC card) with recommendations for these phenotypes extracted from pharmacogenomic drug dosing guidelines.</p>
</div></details><details><summary><div id="faq-496" class="arconix-faq-wrap"><div id="faq-Whataboutdataprivacyifapatientlosesthecard" class="arconix-faq-title faq-closed">What about data privacy if a patient loses the card?</div></summary><div class="arconix-faq-content faq-closed"><p>The pocket card and QR code only contain data on specific PGx markers that can be used to anticipate a patient’s response to certain drugs. The MSC code does not contain any sensitive data on the owner’s health status, risk to develop certain diseases or current medication.</p>
</div></details><details><summary><div id="faq-561" class="arconix-faq-wrap"><div id="faq-WherecanIgetinfomaterialformypatients" class="arconix-faq-title faq-closed">Where can I get infomaterial for my patients?</div></summary><div class="arconix-faq-content faq-closed"><p>You can download infomaterial including an information leaflet for your patients in our <a href="#download">download section.</a></p>
</div></details></p>
<p>If you have any other questions please feel free to <a href="../about-us/">contact us</a>.</p>

<div class="arrow_box_white" style="z-index: 3;">
<h1 id="download">Downloads &#038; References</h1>
<h2>Downloads</h2>
<table class="tg">
<tbody>
<tr>
<th class="tg-031e">Brochures, documentations and other infomaterials</th>
<th class="tg-031e">Link</th>
</tr>
<tr>
<td class="tg-yw4l"> MSC info folder for healthcare providers</td>
<td class="tg-yw4l"><a href="{{ site.baseurl }}/landing-page-theme/docs/healthcare_provider_leaflet.pdf" target="_blank"><img src="http://owl.msi.meduniwien.ac.at/safety-code-org/wordpress/wp-content/uploads/2015/12/download1.png" style="vertical-align:middle;"></a></td>
</tr>
<tr>
<td class="tg-yw4l">MSC info folder for your patients</td>
<td class="tg-yw4l"><a href="{{ site.baseurl }}/landing-page-theme/docs/patient_leaflet.pdf" target="_blank"><img src="http://owl.msi.meduniwien.ac.at/safety-code-org/wordpress/wp-content/uploads/2015/12/download1.png" style="vertical-align:middle;"></a></td>
</tr>
<tr>
<td class="tg-yw4l">Overview of drugs covered by the MSC system (standard version, DPWG guidelines)</td>
<td class="tg-yw4l"><a href="{{ site.baseurl }}/landing-page-theme/docs/drugs_overview_DPWG.pdf" target="_blank"><img src="http://www.safety-code.org/wordpress/wp-content/uploads/2015/12/download1.png" style="vertical-align:middle;"></a></td>
</tr>
</tbody>
</table>
<p></p>
<h2>Selected peer-reviewed scientific papers</h2>
<p>Blagec K, Romagnoli KM, Boyce RD, Samwald M. (2016) <a href="https://doi.org/10.7717/peerj.1671" target="_blank"><strong>„Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study.&#8221;</strong> PeerJ 4:e1671</a></p>
<p>Matthias Samwald and Robert R Freimuth. <a href="http://www.futuremedicine.com/doi/full/10.2217/pgs.13.121" target="_blank"><strong>&bdquo;Making data on essential pharmacogenes available for every patient everywhere: the Medication Safety Code initiative&ldquo;</strong>. <em>Pharmacogenomics </em>14. Nr. 13 (October 2013)</a></p>
<p>Matthias Samwald, Klaus-Peter Adlassnig.  <a href="http://dx.doi.org/10.1136/amiajnl-2012-001275" target="_blank"><strong>&bdquo;Pharmacogenomics in the pocket of every patient? A prototype based on Quick  Response (QR) codes&ldquo; </strong><em>J Am Med Inform Assoc,</em>Published Online First: 23 Jan 2013</a> </p>
<h2>References</h2>
<p>[1] Bouvy, J. C., De Bruin, M. L. &#038; Koopmanschap, M. A. Epidemiology of adverse drug reactions in europe: a review of recent observational studies. Drug Saf. 38, 437–453 (2015).<br />
[2] US Food and Drug Administration (FDA); <a href="http://www.fda.gov" target="_blank">http://www.fda.gov</a>
</div>
	</section></div>